154
Participants
Start Date
December 1, 2011
Primary Completion Date
February 25, 2014
Study Completion Date
February 25, 2014
Levofloxacin
500mg, PO, once daily for 3 months
Capital Health - University of Alberta Hospital, Edmonton
Vancouver General Hospital, Vancouver
St. Paul's Hospital, Vancouver
Winnipeg Health Science Center, Winnipeg
QEII Health Science Center, Halifax
St. Michael's Hospital, Toronto
St. Joseph's Healthcare, Hamilton
London Health Science Center, London
The Ottawa Hospital, Ottawa
University Health Network, Toronto
McGill University Health Center, Montreal
Lead Sponsor
Collaborators (1)
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
St. Paul's Hospital, Canada
OTHER
Vancouver General Hospital
OTHER
University of Alberta
OTHER
University of Manitoba
OTHER
University Health Network, Toronto
OTHER
Unity Health Toronto
OTHER
St. Joseph's Healthcare Hamilton
OTHER
London Health Sciences Centre
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Dalhousie University
OTHER
Ottawa Hospital Research Institute
OTHER